Industry Analysis
In-depth analysis and reports for the Industry Analysis sector.

China's Evolving Industrial Policy: Systemic Expansion and Global Trade Dynamics
An analysis of the shift in China's industrial policy from targeted intervention to systemic expansion, its implications for global value chains, trade dominance, and future economic resilience.

Business Leaders' Outlook for 2026: Navigating Economic Uncertainty and AI Integration
An analysis of business leaders' expectations for 2026, focusing on economic sentiment, the impact of tariffs, and the growing role of Artificial Intelligence in corporate strategy.

China's Evolving Industrial Policy: Systemic Expansion and Global Trade Implications
An analysis of the shift in China's industrial strategy from targeted sectors to systemic industrial policy and its implications for global supply chains, trade dominance, and international competition.

Firearms Market 2026: Regulation, Defense Demand and Manufacturing Innovation
Defense modernization, modular platforms, smart-firearm technology and tightening compliance regimes are reshaping the global firearms industry's competitive landscape.

2026 Global Software Industry Outlook: How Agentic AI Is Redefining Competition
Deloitte's 2026 software outlook signals a decisive shift: financial pressure, agentic AI adoption, and AI-first product design are converging to reset competition across the global software industry.

China’s Next-Generation Industrial Policy and the Global Competitive Shift
China is expanding state intervention across the economy, from critical minerals to AI and clean tech. A new report explains the impact on global supply chains.

How Global Market Research Is Redefining Industry Analysis and Corporate Strategy
An analytical look at how global market research reports and industry analysis are becoming essential tools for executives, investors, and policymakers navigating complex commercial landscapes.

AI Adoption and Personalized Medicine Redefine Biopharmaceutical Competition
The 2026 biopharmaceutical outlook shows cautious optimism, AI-driven R&D, personalized medicine momentum, and a looming patent cliff reshaping global drug development strategy.

Medtech Trends 2026: Global Pricing Pressures and Platform Competition Reshape the Industry
An analysis of the five key medtech trends in 2026, from China's volume-based procurement expansion and the shift to outpatient care to supply chain realignment, GLP-1 impacts, and platform-based competition.

Accelerometer Medical Sensors: The Hidden Enabler of Digital Health Transformation
Accelerometer medical sensors are becoming essential to digital health. With the market set to grow from $1.26B in 2025 to $2.93B by 2034, this analysis explores drivers, regional trends, and strategic implications.

China's Next-Generation Industrial Policy: Expanding State Intervention and Global Market Reach
China's industrial strategy is becoming more systemic, extending across all layers of production. This analysis examines the implications for global trade, supply chains, and corporate competitiveness.

The Biopharmaceutical Industry's 2026 Crossroads: AI Adoption and Pricing Pressures
Explore the key trends shaping the biopharmaceutical industry in 2026, including AI adoption, personalized medicine, pricing pressures, and supply chain resilience.